Year: 2023
Type: preprint
Abstract: Poly(ADP-ribose)ylation or PARylation by PAR polymerase 1 (PARP1) and dePARylation by poly(ADP-ribose) glycohydrolase (PARG) are equally important for the dynamic regulation of DNA damage response. PARG, the most active dePARylation enzyme, is recruited to sites of DNA damage via pADPr-dependent and PCNA-dependent mechanisms. Targeting dePARylation is considered an alternative strategy to overcome PARP inhibitor resistance. However, precisely how dePARylation functions in normal unperturbed cells remains elusive. To address this challenge, we conducted multiple CRISPR screens and revealed that dePARylation of S phase pADPr by PARG is essential for cell viability. Loss of dePARylation activity initially induced S phase-specific pADPr signaling, which resulted from unligated Okazaki fragments and eventually led to uncontrolled pADPr accumulation and PARP1/2-dependent cytotoxicity. Moreover, we demonstrated that proteins involved in Okazaki fragment ligation and/or base excision repair regulate pADPr signaling and cell death induced by PARG inhibition. In addition, we determined that PARG expression is critical for cellular sensitivity to PARG inhibition. Additionally, we revealed that PARG is essential for cell survival by suppressing pADPr. Collectively, our data not only identify an essential role for PARG in normal proliferating cells but also provide a potential biomarker for the further development of PARG inhibitors in cancer therapy.
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: BRCA Answers From Cancer Interactome Structures (BACIS), DNA-Protein Crosslink Repair Pathways and Cancer Therapy, Novel regulations of DNA damage repair, 53BP1-dependent pathway in DNA repair, Processing and Repair of DNA Crosslinks, Define redundant functions of H2AX and NBS1 in DNA repair, Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translation, Studying metabolic stress signaling in renal cancer, Targeting ferroptosis in cancer therapy, Cancer Center Support Grant, Acquired Resistance to Therapy and Iron (ARTI) Center, Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation
OpenAlex ID: W4385480916
